Affiliation:
1. Tan Tock Seng Hospital, Singapore
Abstract
This article traces the development of modern day breast cancer treatment from 1896 when observations were made on the positive response of patients to oophorectomy. The oestrogen receptor was defined and tamoxifen was discovered to be an effective anti-oestrogen. The genes related to breast cancer, BRCA1 and BRCA2, were found to confer high risks of breast and ovarian cancer on women with these genes. The application of functional genomics to breast tumours would result in a more accurate classification of cancers and hopefully more specific therapy and better clinical outcomes. An important off-shoot of anti-oestrogen research has resulted in a new class of drugs called selective oestrogen receptor modulators for treatment of osteoporosis and dyslipidemia.
Publisher
Academy of Medicine, Singapore
Reference34 articles.
1. Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma. Suggestion for a new method of treatment with illustrative cases. Lancet 1896;2:104-7.
2. Boyd S. On oophorectomy in cancer of the breast. Br Med J 1900;2:1161-7.
3. Allen E Dorsy EA. An ovarian hormone. Preliminary report on its localization, extraction and partial purification and action in test animals. JAMA 1923;81:819-21.
4. Jensen EV, Jacobson HI. Basic guides to the mechanism of estrogen action. Recent Prog Horm Res 1962;18:387-414.
5. Jensen EV, Block GE, Smith S, et al. Estrogen receptors and breast cancer response to adrenalectomy. In: Hall TC, editor. Prediction of Response in Cancer Therapy. Monogr Natl Cancer Inst 1971;34:55-70.